Dual-target CAR-NK cells

BIOLOGICAL2 trials

Sponsors

Beijing Biotech

Conditions

Advanced/Metastatic NSCLCGlioblastomaHigh-grade GliomaMalignant GliomaNon-Small Cell Lung CancerRecurrent GlioblastomaRecurrent High-grade Glioma

Phase 1

Dual-Target CAR-NK Cells Directed Against MSLN, EGFR, or HER2 in Advanced NSCLC

RecruitingNCT07467863

Beijing BiotechAdvanced/Metastatic NSCLC, Non-Small Cell Lung Cancer

Start: 2026-02-02End: 2028-02-17Target: 48Updated: 2026-03-12

Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma

RecruitingNCT07480941

Beijing BiotechGlioblastoma, High-grade Glioma, Malignant Glioma +2

Start: 2026-02-02End: 2028-03-17Target: 36Updated: 2026-03-18